[Cost-effectiveness analysis of prevention of reinfarction using low-dose acetylsalicylic acid; model calculation].

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Sozial- und Präventivmedizin

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Economics

• Identifiers
  PMID 9221624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The benefits of aspirin in acute myocardial infarction. Still a well-kept secret in the United States.

  1994cited by this paper
• [Drug treatment of patients with heart infarcts before and after the acute stage: results of the Heart Infarct Registry Augsburg].

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

  1994cited by this paper
• Aspirin to prevent heart attack or stroke

  1994cited by this paper
• Discounting of Health Benefits in the Pharmacoeconomic Analysis of Drug Therapies

  1992cited by this paper
• The cost of migraine: more than just a headache?

  1992cited by this paper
• Cost-of-illness studies: a major headache?

  1992cited by this paper
• [Population-based heart infarct register in the Augsburg region: possibilities and limitations].

  1991cited by this paper
• A reason for visit classification for ambulatory care.

  1979cited by this paper

• Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events

  2012cites this paper
• Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective.

  2004cites this paper
• Characterization of prostaglandin endoperoxide H synthase-1 enzyme expression during differentiation of the megakaryocytic cell line MEG-01.

  2000cites this paper